This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1987 Dec;138(6):1363-8.

doi: 10.1016/s0022-5347(17)43644-5.

An overview of intravesical therapy for superficial bladder tumors

H W Herr¹, V P Laudone, W F Whitmore Jr

Affiliations

PMID: 3316712
DOI: 10.1016/s0022-5347(17)43644-5

Review

An overview of intravesical therapy for superficial bladder tumors

H W Herr et al. J Urol. 1987 Dec.

. 1987 Dec;138(6):1363-8.

doi: 10.1016/s0022-5347(17)43644-5.

Authors

H W Herr¹, V P Laudone, W F Whitmore Jr

Affiliation

¹ Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

PMID: 3316712
DOI: 10.1016/s0022-5347(17)43644-5

No abstract available

PubMed Disclaimer

Similar articles

Impact of intravesical chemotherapy on recurrence rate of recurrent superficial transitional cell carcinoma of the bladder: results of a meta-analysis.
Huncharek M, McGarry R, Kupelnick B. Huncharek M, et al. Anticancer Res. 2001 Jan-Feb;21(1B):765-9. Anticancer Res. 2001. PMID: 11299841
Intravesical therapy. A critical review.
Herr HW. Herr HW. Urol Clin North Am. 1987 May;14(2):399-404. Urol Clin North Am. 1987. PMID: 3554695 Clinical Trial.
Only an overall 15% net benefit emerges in favour of adjuvant intravesical chemotherapy when compared to transurethral resection alone for the prevention of recurrences of superficial bladder tumors.
Colombo R. Colombo R. Eur Urol. 2006 Aug;50(2):233-4. Eur Urol. 2006. PMID: 18219715 No abstract available.
New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
van der Meijden AP. van der Meijden AP. Prog Clin Biol Res. 1992;378:95-101. Prog Clin Biol Res. 1992. PMID: 1301591 Review. No abstract available.
BCG versus cytotoxic chemotherapy in the treatment of superficial bladder tumors.
Boccon-Gibod L. Boccon-Gibod L. Prog Clin Biol Res. 1992;378:55-7. Prog Clin Biol Res. 1992. PMID: 1301586 Review. No abstract available.

See all similar articles

Cited by

Prospective randomized comparison of intravesical BCG therapy with standard dose versus low doses in superficial bladder cancer.
Yalçinkaya F, Kamiş L, Ozteke O, Günlüsoy B, Yigitbaşi O, Unal S. Yalçinkaya F, et al. Int Urol Nephrol. 1998;30(1):41-4. doi: 10.1007/BF02550276. Int Urol Nephrol. 1998. PMID: 9569110 Clinical Trial.
Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index.
Lipponen PK, Eskelinen MJ, Jauhiainen K, Harju E, Terho P, Haapasalo H. Lipponen PK, et al. J Cancer Res Clin Oncol. 1992;118(8):615-20. doi: 10.1007/BF01211807. J Cancer Res Clin Oncol. 1992. PMID: 1517282 Free PMC article.
Intravesical administration of pirarubicin against superficial bladder cancer: Relationship between tumor tissue concentration and exposure time in the bladder or therapeutic effect.
Arakawa M, Nakamura K, Yamada Y, Kato K, Katsuda R, Tobiume M, Zennami K, Watanabe M, Kato Y, Nishikawa G, Yoshizawa T, Aoki S, Taki T, Mitsui K, Honda N, Saito H, Hasegawa T. Arakawa M, et al. Exp Ther Med. 2011 Sep;2(5):901-905. doi: 10.3892/etm.2011.315. Epub 2011 Jun 30. Exp Ther Med. 2011. PMID: 22977595 Free PMC article.
Treatment of experimental mouse bladder tumour by LPS-induced epithelial cell shedding.
Nativ O, Medalia O, Mor Y, Shajrawi I, Sabo E, Aronson M. Nativ O, et al. Br J Cancer. 1996 Aug;74(4):603-5. doi: 10.1038/bjc.1996.408. Br J Cancer. 1996. PMID: 8761377 Free PMC article.
Periostin suppresses in vivo invasiveness via PDK1/Akt/mTOR signaling pathway in a mouse orthotopic model of bladder cancer.
Kim CJ, Tambe Y, Mukaisho KI, Sugihara H, Kageyama S, Kawauchi A, Inoue H. Kim CJ, et al. Oncol Lett. 2017 Jun;13(6):4276-4284. doi: 10.3892/ol.2017.6004. Epub 2017 Apr 7. Oncol Lett. 2017. PMID: 28599427 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information